Disclosure Of Fair Value Measurement [Text Block]

ERYTECH Pharma S.A. - Filing #880081

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31
Disclosure of fair value measurement [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets	—	66 768 EUR	—	—	—	—	—	—	—	—	80 402 EUR	—	—	—	—	118 545 EUR	—	—	—	—	—	—	—	—
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity	25 293 EUR	22 845 EUR	53 797 EUR	97 618 EUR	1 215 EUR	3 102 EUR	2 006 EUR	1 744 EUR	24 616 EUR	120 705 EUR	26 539 EUR	73 300 EUR	136 607 EUR	1 344 EUR	281 688 EUR	85 560 EUR	1 794 EUR	62 659 EUR	99 524 EUR	188,000 EUR	281 744 EUR	145 602 EUR	1 794 EUR	38 224 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]